Expression of PARP-1 in Optic Neuritis of Multiple Sclerosis Patients

Trial Information
Status: Recruiting
Location: See location...
Intervention Type: Genetic
Study Type: Interventional
Study Phase: Not Applicable

This study will explore the expression of PARP-1 in optic neuritis of multiple sclerosis patients. The data will be collected from Sohag University hospital in the period from the start of August 2021 to the end of December 2021. The study protocol will be approved by the Scientific Research Ethical Committee, Faculty of Medicine, Sohag University.

Am I eligible for this trial?
Participation Requirements
Minimum Age:
Maximum Age:
Healthy Volunteers:
Accepts Healthy Volunteers

• Patients with multiple sclerosis with or without optic neuritis Multiple sclerosis will be diagnosed according to the McDonald criteria

Where is this trial taking place?
Other Locations
Elshimaa A.Mateen
When is this trial taking place?
Start Date: August 1, 2021
Estimated Completion Date: April 2022
How many participants will be in this trial?
Target number of participants: 80
What treatment is being studied in this trial?
Other: Control group
Active Comparator: MS with optic neuritis
Active Comparator: Ms without optic neuritis

This content was sourced from